학술논문

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study
Document Type
Article
Source
In: The Lancet Haematology. (The Lancet Haematology, December 2020, 7(12):e861-e873)
Subject
Language
English
ISSN
23523026